Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3014114	s-aurpulg	mg/l (—)	56	58	100.00%	Distribution not available
3014114	s-aurpulg	— (—)	55	57	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma (only as main-diagnosis)

42.50

29.80

1.0

—

Asthma (only as main-diagnosis), excluding more controls

41.03

28.84

1.0

—

Abnormal findings on diagnostic imaging of lung

9.33

28.77

1.1

1.0

—

Asthma, unspecified (mode)

52.82

27.03

1.0

—

Asthma, unspecified (mode), excluding more controls

52.48

26.95

1.0

—

Asthma, hospital admissions , main diagnosis only

6.51

26.58

1.0

—

Asthma

35.87

26.02

1.0

—

Asthma, excluding more controls

35.68

25.95

1.0

—

ILD, hospital admissions

33.16

25.51

1.0

—

Interstitial lung disease endpoints

33.16

25.51

1.0

—

Other interstitial pulmonary diseases

33.16

25.51

1.0

—

Interstitial lung disease

33.16

25.51

1.0

—

Asthma (mode)

30.60

24.83

1.0

—

Other respiratory diseases principally affecting the interstitium

27.60

24.41

1.0

—

ILD, hospital admissions 1, main diag only

34.62

24.24

1.0

—

Diagnoses used for exclusion with ILD

20.64

23.81

1.1

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

5.88

23.41

1.0

—

Asthma (diagnoses ohter than nonallergic)

5.83

23.39

1.0

—

Asthma, hospital admission 2, infections

7.52

23.13

1.0

1.1

—

Asthma-related infections

7.52

23.13

1.0

1.1

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

44.08

22.86

1.0

—

Chronic lower respiratory diseases

5.75

22.64

1.1

1.0

—

Influenza and pneumonia

5.68

22.58

1.0

—

All pneumoniae

5.63

21.99

1.0

—

6.68

21.84

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

6.68

21.84

1.0

—

Pneumonia, organism unspecified

5.84

21.82

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

6.25

21.19

1.1

1.0

—

ILD, hospital admission 2, with pulmonary infections

40.26

19.48

1.0

—

Lung diseases due to external agents

22.59

19.02

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

5.12

18.96

1.0

—

ILD medications

5.00

17.49

1.0

—

Oral corticosteroids

4.87

17.39

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

5.04

17.12

1.0

—

Asthma, including avohilmo

4.51

16.66

1.0

—

ILD, hospital admissions 3, with pneumonia sepsis

40.26

16.32

1.0

—

Excluding asthma or asthma-COPD overlap

23.38

16.14

1.0

—

COPD differential diagnosis

20.04

15.51

1.0

—

ILD differential diagnosis

20.04

15.51

1.0

—

Other pulmonary diagnosis

22.55

15.44

1.0

—

Inflammatory bowel disease treatment related agents

4.32

14.27

1.0

—

Asthma/COPD (KELA code 203)

4.90

14.18

1.1

1.0

—

6.62

13.85

1.0

—

Asthma-related pneumonia

9.61

12.66

1.0

—

Asthma-related pneumonia or sepsis

9.61

12.66

1.0

—

Asthma, hospital admissions 3, pneumonia

9.61

12.66

1.0

—

First line medication for Crohn's disease

4.16

12.28

1.0

—

Diseases of the respiratory system

15.04

10.81

1.0

—

COPD/asthma/ILD related infections

4.37

10.70

1.1

1.0

—

COPD/asthma related infections

4.37

10.70

1.1

1.0

—

Cough

7.72

9.86

1.0

—

Idiopathic pulmonary fibrosis

26.09

9.81

1.0

—

ILD medications: immunosuppressive drugs

4.26

8.52

1.0

—

Chronic sinusitis

4.74

8.09

1.2

1.0

—

Abnormalities of breathing

3.54

7.33

1.1

1.0

—

Mycoses

6.81

7.27

1.1

1.0

—

Bacterial pneumonia (organism specified)

5.75

7.07

1.0

—

Mycoses

2.97

6.39

1.1

1.0

—

Other diseases of pleura

4.01

5.68

1.1

1.0

—

FESS (DNB20)

8.48

5.55

1.1

1.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

5.77

5.46

1.1

1.0

—

Ethmoidectomy

7.87

5.34

1.1

1.0

—

Candidiasis

5.91

5.21

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

2.94

5.19

1.0

—

Bronchiectasis

13.36

5.08

1.1

1.0

—

Acute sinusitis

3.33

5.05

1.1

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

7.53

4.83

1.1

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3.30

4.77

1.1

1.0

—

Dyspnoea

2.63

4.67

1.0

—

Bacterial pneumoniae

5.57

4.56

1.0

—

Bacterial pneumonia, not elsewhere classified

5.56

4.56

1.0

—

Metabolic disorders

2.48

4.27

1.0

—

2.58

4.25

1.1

1.0

—

Obesity related asthma

4.80

4.17

1.0

—

Other diseases of upper respiratory tract

2.47

4.08

1.1

1.0

—

Fever of other and unknown origin

2.82

4.07

1.0

1.1

—

Pleural effusion

8.01

4.06

1.1

1.0

—

Persons encountering health services in other circumstances, wide

2.35

4.05

1.0

—

Disorders of other endocrine glands

3.83

3.91

1.1

1.0

—

Suggestive for eosinophilic asthma

7.29

3.85

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

4.29

3.81

1.1

1.0

—

Supervision of normal pregnancy

6.43

3.55

1.1

1.3

—

Autoimmune diseases excluding thyroid diseases, strict definition

2.25

3.46

1.0

—

Pain in throat and chest

2.59

3.21

1.0

—

L04AA Selective immunosuppressants

4.17

3.19

1.1

1.0

—

Candidiasis

6.37

3.18

1.0

—

Acute upper respiratory infections

2.23

3.14

1.1

1.0

—

Autoimmune diseases excluding thyroid diseases

2.15

3.14

1.0

—

Other chronic obstructive pulmonary disease

3.78

3.08

1.0

—

Other chronic obstructive pulmonary disease, including avohilmo

2.75

3.07

1.1

1.0

—

COPD

3.75

3.05

1.0

—

Any reimbursement code in KELA

2.86

3.03

1.1

1.0

—

Acute pharyngitis

5.79

3.00

1.0

—

Haemorrhage from respiratory passages

3.92

2.98

1.1

1.0

—

Viral pneumonia

5.39

2.86

1.0

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

8.34

2.75

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.08

2.71

1.0

—

6.00

2.69

1.0

—

Other viral diseases

3.44

2.68

1.1

1.0

—

Certain disorders involving the immune mechanism

4.21

2.67

1.1

1.0

—

Nasal polyp

4.21

2.67

1.0

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

3.66

2.55

1.0

—

Autoimmune diseases related-to ILD

2.31

2.52

1.0

1.1

—

Other disorders of urethra and urinary system

2.41

2.49

1.1

—

Infective dermatitis

4.38

2.47

1.0

—

Other bacterial diseases

2.02

2.47

1.0

—

Exclusions for E4_PCOS_BROAD

3.81

2.46

1.1

1.0

—

Acute bronchitis

2.91

2.42

1.1

1.0

—

Urticaria

3.33

2.39

1.1

1.0

—

Other acute lower respiratory infections

2.43

2.36

1.1

1.0

—

All influenza

4.12

2.35

1.0

—

Disorders of lipoprotein metabolism and other lipidaemias

2.10

2.35

1.0

—

Vocal cord dysfunction

4.90

2.32

1.3

1.0

—

Voice disturbances

3.22

2.30

1.0

—

Gastrointestinal diseases

2.51

2.30

1.1

1.0

—

Sarcoidosis

4.62

2.27

1.2

1.0

—

Persons encountering health services in other circumstances

2.74

2.25

1.0

—

COPD, hospital admission 2, with asthma infections

2.96

2.25

1.0

—

Other problems related to primary support group, including family circumstances

5.41

2.16

1.2

1.0

—

Other disorders of bladder

4.29

2.15

1.0

—

Other bacterial diseases

1.90

2.12

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1.94

2.10

1.0

—

Osteopathies and chondropathies

2.29

2.10

1.0

1.1

—

Persons encountering health services in circumstances related to reproduction

2.20

2.06

1.0

1.1

—

Premature rupture of membranes

4.29

2.04

1.0

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

2.16

2.01

1.2

1.0

—

Non-invasive ventilation

3.11

2.00

1.0

—

Urticaria and erythema

2.81

1.99

1.1

1.0

—

Other viral diseases

2.61

1.98

1.1

1.0

—

Acute and subacute iridocyclitis

3.34

1.96

1.0

—

Anterior Iridocyclitis

3.33

1.96

1.0

—

Sulfasalazine

3.33

1.96

1.0

—

COPD, hospital admissions

2.51

1.96

1.0

—

COPD, early/later onset

2.51

1.95

1.0

—

Scoliosis

4.55

1.94

1.0

1.1

—

Symptoms and signs involving speech and voice

2.73

1.93

1.0

—

Endocrine, nutritional and metabolic diseases

1.99

1.90

1.1

1.0

—

Ischaemic heart disease, wide definition

2.03

1.89

1.0

—

Renal failure

2.43

1.86

1.0

—

Osteoporosis

3.12

1.82

1.0

—

Diabetic maculopathy, excluding more controls

4.17

1.82

1.0

—

Special screening examination for other diseases and disorders

4.17

1.82

1.0

—

L04AX Other immunosuppressants

2.12

1.81

1.0

—

Early onset COPD

3.05

1.79

1.0

—

Other noninflammatory disorders of uterus, except cervix

3.67

1.79

1.0

1.2

—

Postpartum hemorraghe, all women as controls

3.28

1.71

1.2

1.1

—

Bacterial infection, other or unspecified

2.15

1.70

1.0

—

Allergic rhinitis

2.64

1.69

1.0

—

Other diseases of urinary system

1.84

1.69

1.0

—

Procreative management

2.67

1.68

1.0

1.1

—

Chronic kidney disease

2.62

1.68

1.0

—

Peritonsillar abscess

3.16

1.66

1.0

—

Chronic gastritis

3.16

1.66

1.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.99

1.64

1.1

1.0

—

Second line medication for Crohn's disease

2.03

1.64

1.0

—

Reimbursement for rheumatic diseases

2.09

1.63

1.0

—

Insulin, fast-acting

2.38

1.61

1.1

1.0

—

Diseases of the musculoskeletal system and connective tissue

2.13

1.59

1.0

1.1

—

Factors influencing health status and contact with health services

2.82

1.58

1.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

2.69

1.58

1.0

—

Other/unspecified seropositive rheumatoid arthritis

2.69

1.58

1.0

—

Dermatitis and eczema

1.71

1.57

1.1

1.0

—

Other viral diseases, not elsewhere classified

2.99

1.57

1.2

1.0

—

Paracetamol or NSAID medication

2.94

1.57

1.0

1.1

—

Vasomotor and allergic rhinitis

2.45

1.55

1.0

—

Postpartum hemorraghe, parous women as controls

3.00

1.55

1.2

1.0

—

Insulin, fast-acting or short human

2.27

1.55

1.1

1.0

—

Postpartum haemorrhage

2.97

1.53

1.2

1.1

—

Tumor necrosis factor alpha inhibitors

3.33

1.52

1.0

1.1

—

Used for control exclusion in common control thyroid runs

1.73

1.52

1.0

—

Iridocyclitis

2.59

1.51

1.0

—

Seropositive rheumatoid arthritis, wide

2.59

1.51

1.0

—

Psoriasis vulgaris

2.86

1.50

1.0

—

Other respiratory disorders and diseases

2.86

1.50

1.0

—

Other diseases of the respiratory system

2.86

1.50

1.0

—

Abnormal findings on examination of blood, without diagnosis

2.08

1.48

1.0

—

COPD related to multimorbidity

2.45

1.48

1.0

—

Dorsalgia

1.73

1.47

1.0

—

Any death

1.92

1.45

1.0

—

Other disorders of bone

2.73

1.43

1.0

—

Acute renal failure

2.73

1.43

1.0

—

Type 1 diabetes, wide definition, subgroup 1

2.73

1.43

1.0

—

Type 1 diabetes, wide definition

2.73

1.43

1.0

—

Solid cancers, helper endpoint

0.39

1.42

1.0

—

Type 1 diabetes

2.41

1.39

1.0

—

Insulin medication

1.86

1.37

1.1

1.0

—

Dermatitis

1.93

1.36

1.1

1.0

—

Pre-eclampsia or poor fetal growth

2.60

1.36

1.2

1.1

—

Seropositive rheumatoid arthritis, strict definition

2.94

1.36

1.0

—

Biological medication for rheuma

2.94

1.36

1.0

1.1

—

Nontoxic multinodular goitre

2.94

1.36

1.4

1.0

—

Coronary atherosclerosis

1.93

1.34

1.0

—

Diseases of oesophagus, stomach and duodenum

1.67

1.34

1.0

1.1

—

Malignant neoplasm, wide definition for exclusion

0.45

1.34

1.0

—

Insulin, intermediate and long-acting

1.91

1.32

1.0

—

Anaemias

2.49

1.32

1.0

—

Diabetes, varying definitions

1.65

1.30

1.0

—

Autoimmune diseases

1.65

1.30

1.0

—

Diabetes mellitus

1.65

1.29

1.0

—

Other reaction to severe stress, and adjustment disorders

2.35

1.29

1.1

1.0

—

Injury, poisoning and certain other consequences of external causes

1.88

1.28

1.0

1.1

—

Noninflammatory disorders of female genital tract

2.36

1.26

1.0

1.2

—

Type 2 diabetes, wide definition

1.72

1.25

1.0

—

Diabetic retinopathy

2.27

1.24

1.0

—

COPD, hospital admissions 1, only main diagnosis

2.21

1.23

1.0

—

Pure hypercholesterolaemia

1.77

1.22

1.0

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

2.44

1.21

1.0

1.1

—

Unspecified acute lower respiratory infection

2.63

1.21

1.2

1.0

—

Other gastritis (incl. Duodenitis)

2.63

1.21

1.0

—

Malignant neoplasm

0.45

1.21

1.0

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2.16

1.21

1.1

—

Tonsillectomy and adenotomy

1.94

1.21

1.0

—

Other and unspecified tonsillitis

2.17

1.21

1.0

—

Anxiety disorders, excluding more controls

1.70

1.20

1.1

1.0

—

Complications of labour and delivery

2.14

1.20

1.0

1.1

—

Diseases of liver

2.11

1.18

1.0

—

Rheumatoid arthritis

2.11

1.18

1.0

—

Other viral diseases, not elsewhere classified

2.30

1.17

1.2

1.0

—

Bronchitis

1.61

1.17

1.1

1.0

—

External causes of morbidity and mortality

1.74

1.17

1.0

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

2.13

1.16

1.1

—

Other diseases of liver

2.50

1.15

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

1.83

1.13

1.0

—

Speech therapy

2.33

1.12

1.0

—

Other and unspecified anaemias

2.01

1.12

1.0

—

Rheumatoid arthritis, including avohilmo

2.00

1.12

1.0

—

Other anaemias

2.00

1.11

1.0

—

Bacterial infection, other or unspecified

1.91

1.11

1.0

—

Seropositive rheumatoid arthritis

2.25

1.10

1.0

—

GASTRO-related operations

1.67

1.10

1.1

1.0

—

Any gastric operation

1.67

1.10

1.1

1.0

—

Diseases of male genital organs

1.81

1.10

1.0

—

Phlebitis and thrombophlebitis (not including DVT)

2.38

1.09

1.0

—

Excessive, frequent and irregular menstruation

2.26

1.08

1.0

1.2

—

Certain infectious and parasitic diseases

1.75

1.06

1.1

1.0

—

Any event in cancer register

0.52

1.03

1.0

—

Deforming dorsopathies

2.06

1.02

1.0

1.1

—

Parasetamol

1.66

1.02

1.0

—

Sub-endpoint used in defining T1D endpoints

2.03

1.01

1.0

—

Persons encountering health services for examination and investigation

1.76

1.01

1.1

1.0

—

Neurological diseases, wide definition

2.51

0.99

1.0

1.1

—

Anxiety disorders

1.59

0.99

1.1

1.0

—

Other bacterial intestinal infections

2.17

0.98

1.0

—

Other disorders of lacrimal gland

1.94

0.97

1.0

1.1

—

Intestinal stricture

0.00

0.95

0.0

1.0

—

All chronic kidney diseases

1.80

0.94

1.0

—

Depression or dysthymia

1.64

0.94

1.0

—

Nonsuppurative otitis media

2.26

0.94

1.0

—

Abdominal and pelvic pain

1.55

0.93

1.0

—

Other noninfective gastroenteritis and colitis

2.22

0.93

1.0

—

Pain (limb, back, neck, head abdominally)

1.67

0.93

1.0

1.1

—

Endometriosis

2.20

0.92

1.0

1.2

—

Atopic dermatitis, strict definition with reimbursement

2.07

0.89

1.2

1.0

—

Intestinal infectious diseases

1.48

0.88

1.1

1.0

—

Bleeding

1.58

0.88

1.1

1.0

—

Cardiovascular diseases

1.70

0.88

1.0

1.1

—

Pregnancy with abortive outcome

1.86

0.87

1.0

1.1

—

Aplastic and other anaemias

1.86

0.87

1.0

—

Certain infectious and parasitic diseases

1.58

0.87

1.1

1.0

—

All kidney diseases

1.51

0.87

1.0

—

Acute suppurative otitis media

2.00

0.86

1.2

1.0

—

Excessive attrition of teeth

1.72

0.86

1.1

1.0

—

Single spontaneous delivery

1.99

0.84

1.0

1.1

—

Diabetic retinopathy, excluding more controls

1.98

0.84

1.0

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

1.66

0.83

1.0

1.1

—

Other diseases of the digestive system

1.87

0.81

1.2

1.0

—

GI-bleeding

1.87

0.81

1.2

1.0

—

Gonarthrosis,primary

0.55

0.80

1.1

1.0

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.49

0.80

1.1

1.0

—

Insomnia

0.55

0.79

1.0

—

Psoriasis

1.82

0.79

1.0

—

Other and unspecified nonorganic psychotic disorders

0.00

0.79

0.0

1.0

—

Ventral hernia

0.00

0.79

0.0

1.0

—

Disorders of vestibular function (Vertigo)

1.67

0.79

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.65

0.78

1.0

—

Fall on same level

0.62

0.78

1.1

1.0

—

Superficial injury of head

0.00

0.78

0.0

1.0

—

Paralytic ileus and intestinal obstruction

0.00

0.78

0.0

1.0

—

Neurotic, stress-related and somatoform disorders

1.51

0.78

1.1

1.0

—

Medical abortion

1.74

0.77

1.0

1.1

—

Sleep apnoea, including avohilmo

1.47

0.77

1.0

1.1

—

Disorders of synovium and tendon

1.66

0.76

1.0

1.1

—

Systemic connective tissue disorders

1.76

0.76

1.0

—

Deviated nasal septum

1.76

0.76

1.0

—

Abnormalities of heart beat

2.13

0.75

1.0

—

Nausea and vomiting

2.13

0.75

1.0

—

Spondylopathies

1.54

0.75

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1.67

0.75

1.0

1.1

—

Hypertensive diseases (excluding secondary)

1.68

0.74

1.0

1.1

—

Coronary artery bypass grafting

2.07

0.74

1.0

—

Retention of urine

1.85

0.74

1.0

—

Viral warts

2.00

0.72

1.0

—

Female infertility

2.02

0.72

1.0

1.1

—

Ischemic heart diseases

1.50

0.72

1.0

—

Atrial fibrillation and flutter with reimbursement

1.99

0.71

1.0

1.1

—

Periodontitis

0.63

0.71

1.0

—

Cystitis

1.58

0.71

1.0

1.1

—

Visual disturbances and blindness

1.58

0.71

1.2

1.0

—

Suppurative and unspecified otitis media

1.72

0.70

1.1

1.0

—

Pain in joint

1.63

0.69

1.0

1.1

—

Enthesopathies of lower limb, excluding foot

1.85

0.68

1.2

1.0

—

Benign paroxysmal vertigo

1.85

0.68

1.0

—

Nontoxic goitre/thyroid nodule

1.85

0.68

1.4

1.0

—

Other diseases of blood and blood-forming organs, wide

1.79

0.66

1.0

—

Other systemic involvement of connective tissue

1.79

0.66

1.0

—

Other/unspecified dorsalgia

1.61

0.66

1.0

—

Anti-inflammatory and antirheumatic products, non-steroids

1.75

0.65

1.0

—

Low back pain

1.50

0.65

1.0

—

Other disorders of fluid, electrolyte and acid-base balance

1.76

0.65

1.0

—

Implicit bacterial Sepsis

1.59

0.65

1.0

—

Gonarthrosis [arthrosis of knee](FG)

0.55

0.64

1.2

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.41

0.63

1.1

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

1.40

0.63

1.1

1.0

—

Other anxiety disorders

1.65

0.62

1.0

—

Intestinal infectious diseases

1.42

0.62

1.1

1.0

—

Gastro-oesophageal reflux disease

1.52

0.61

1.0

1.1

—

Chronic periodontitis, including avohilmo

0.63

0.61

1.0

—

Contraceptive management

1.60

0.61

1.0

1.1

—

Other disorders of patella

0.00

0.60

0.0

1.0

—

Dysphagia

0.00

0.60

0.0

1.0

—

Genitourinary diseases

1.52

0.60

1.0

1.1

—

Injury of eye and orbit

0.00

0.60

0.0

1.0

—

Malignant melanoma, including Hilmo

0.00

0.60

0.0

1.0

—

Malignant neoplasm of colon, including Hilmo

0.00

0.60

0.0

1.0

—

Diseases of pulp and periapical tissues and dental caries

1.51

0.60

1.0

—

Sleep apnoea

1.41

0.60

1.0

—

Inflammatory diseases of female pelvic organs

1.55

0.59

1.0

1.1

—

Constipation

1.42

0.59

1.0

1.1

—

Visual disturbances

1.51

0.58

1.3

1.0

—

Exposure to other specified factors

1.44

0.58

1.1

1.0

—

Benign neoplasms

1.38

0.58

1.0

1.1

—

Diseases of the skin and subcutaneous tissue

1.38

0.57

1.1

1.0

—

Atrial fibrillation and flutter

1.69

0.57

1.0

1.1

—

Spontaneous abortion

1.69

0.57

1.0

1.1

—

Dental pulpitis, including avohilmo

1.40

0.57

1.1

1.0

—

Symptoms and signs involving the digestive system and abdomen

1.39

0.56

1.0

—

Other heart diseases

1.55

0.56

1.0

1.1

—

Malaise and fatigue

1.54

0.55

1.0

—

Sleep disorders

0.63

0.55

1.0

—

General symptoms and signs

1.35

0.54

1.0

1.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.48

0.54

1.0

1.1

—

Other retinal disorders

1.50

0.54

1.1

1.0

—

Polycystic ovarian syndrome, consortium definition

1.56

0.53

1.0

1.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

1.56

0.53

1.2

1.0

—

Spinal stenosis

1.45

0.53

1.0

—

Other disorders of skin and subcutaneous tissue

1.46

0.53

1.1

1.0

—

Other arthritis (FG)

1.50

0.51

1.0

1.1

—

Covid-19 confirmed case

1.50

0.51

1.0

—

Hyperplasia of prostate

1.59

0.50

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

0.68

0.50

1.0

—

Disorders of lacrimal system

1.55

0.48

1.0

1.1

—

Gingivitis and periodontal diseases

0.69

0.48

1.0

—

Other diseases of hard tissues of teeth

0.57

0.48

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.34

0.47

1.0

—

Antihypertensive medication - note that there are other indications

1.45

0.47

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1.48

0.47

1.0

—

Mood [affective] disorders

1.33

0.47

1.0

—

Cardiac arrhythmias

1.46

0.46

1.0

1.1

—

Mood disorders

1.32

0.46

1.0

—

Dental caries, including avohilmo

1.41

0.46

1.0

—

Percutaneous Coronary Intervention

1.38

0.46

1.0

—

Coronary revascularization (ANGIO or CABG)

1.38

0.46

1.0

—

Obesity and other hyperalimentation

0.62

0.45

1.0

1.1

—

Obesity

0.62

0.45

1.0

1.1

—

Other maternal disorders predominantly related to pregnancy

1.42

0.45

1.0

1.1

—

Menorrhagia

1.73

0.45

1.0

1.2

—

Implicit bacterial Sepsis

1.41

0.45

1.0

—

Ovarian cyst

1.70

0.44

1.0

1.2

—

Artificial joint operation, meniscal resection

0.69

0.44

1.0

—

Delivery

1.65

0.44

1.0

1.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

0.69

0.44

1.0

—

Renal tubulo-interstitial diseases

1.35

0.44

1.0

—

All anxiety disorders

1.42

0.43

1.0

—

Hypertensive Heart Disease

1.63

0.43

1.0

—

Heart failure, not strict

1.38

0.43

1.0

—

Emergency coronary revascularization (for ACS)

1.34

0.42

1.0

—

Chronic apical periodontitis

0.73

0.42

1.0

—

Bacterial Sepsis

1.39

0.42

1.0

—

Valvular heart disease excluding rheumatic fever

1.38

0.41

1.0

—

Non-rheumatic valve diseases

1.37

0.41

1.0

—

Combinations of oral blood glucose lowering drugs

1.52

0.41

1.0

—

Benign lipomatous neoplasm

1.52

0.41

1.0

—

Other and unspecified iron deficiency

1.51

0.41

1.0

—

Superficial injury of shoulder and upper arm

0.00

0.41

0.0

1.0

—

Diseases of the myoneural junction and muscle

0.00

0.41

0.0

1.0

—

Acute and transient psychotic disorders

0.00

0.41

0.0

1.0

—

Lateral epicondylitis

0.00

0.41

0.0

1.0

—

Assault

0.00

0.41

0.0

1.1

—

Parkinson's disease, including avohilmo

0.00

0.41

0.0

1.0

—

DVT of lower extremities

0.00

0.41

0.0

1.0

—

Lesion of ulnar nerve

0.00

0.41

0.0

1.0

—

Malignant neoplasm of colon

0.00

0.41

0.0

1.0

—

Conduction disorders

1.50

0.41

1.0

—

Arthrosis

0.65

0.41

1.0

—

Hypertensive heart and/or renal disease

1.49

0.41

1.0

—

Other systemic involvement of connective tissue (FG)

1.50

0.41

1.0

1.1

—

Lower back pain or/and sciatica

1.29

0.40

1.0

—

Type 2 diabetes

1.31

0.40

1.0

—

Non-Hodgkin lymphoma, all, including Hilmo

0.00

0.40

0.0

1.0

—

Macular pucker

0.00

0.40

0.0

1.0

—

Other disorders of the musculoskeletal system and connective tissue

0.00

0.40

0.0

1.0

—

Malignant melanoma of skin, including Hilmo

0.00

0.40

0.0

1.0

—

Familial hypercholesterolemia

0.00

0.40

0.0

1.0

—

Colectomy operation

0.00

0.40

0.0

1.0

—

Malignant melanoma

0.00

0.40

0.0

1.0

—

Other or unspecified ileus, impaction or obstruction

0.00

0.40

0.0

1.0

—

Open wound of wrist and hand

1.33

0.40

1.1

1.0

—

Pregnancy hypertension

1.44

0.39

1.0

1.1

—

Diseases of inner ear

1.31

0.39

1.0

—

Heart failure and antihypertensive medication

1.42

0.39

1.0

—

Other skin changes

0.00

0.39

0.0

1.1

—

Dental caries

1.41

0.39

1.0

—

Disorders of choroid and retina

1.33

0.38

1.1

1.0

—

Other diseases of intestines

1.27

0.38

1.0

—

Atopic dermatitis

1.34

0.38

1.1

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.30

0.38

1.0

—

Spondylosis

1.33

0.38

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.35

0.37

1.1

1.0

—

Examination and observation for other reasons

1.30

0.37

1.0

—

Fall on same level involving ice and snow

1.30

0.37

1.0

—

Other arthrosis

0.65

0.36

1.0

—

Coxibs

1.44

0.36

1.0

—

Stroke, including SAH

0.61

0.36

1.0

—

Benzodiazepine use

1.27

0.35

1.0

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.42

0.35

1.0

1.1

—

Psychiatric diseases

1.27

0.35

1.1

1.0

—

Other disorders of veins

1.39

0.35

1.0

—

Major coronary heart disease event excluding revascularizations

1.39

0.34

1.0

—

Hyperlipidaemia, other/unspecified

1.38

0.34

1.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.36

0.34

1.0

—

Disorders of gallbladder, biliary tract and pancreas

1.28

0.34

1.1

1.0

—

Episodal and paroxysmal disorders

1.25

0.33

1.0

1.1

—

Unspecified mental disorder

1.30

0.33

1.0

—

Papulosquamous disorders

1.28

0.32

1.0

—

Other antidepressants

1.23

0.30

1.1

1.0

—

Mouth breathing

1.29

0.30

1.0

—

Unspecified fall

1.28

0.30

1.1

1.0

—

Transient ischemic attack

1.23

0.29

1.0

—

Cholecystectomy

1.33

0.29

1.1

1.0

—

Heart failure,strict

1.28

0.28

1.0

—

Angina pectoris

1.27

0.28

1.0

—

Major coronary heart disease event

1.26

0.28

1.0

—

Injuries to the shoulder and upper arm

0.77

0.27

1.0

—

All-cause Heart Failure

1.23

0.27

1.0

—

Heart failure, strict

1.23

0.27

1.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.23

0.27

1.0

—

Other soft tissue disorders, not elsewhere classified

1.24

0.26

1.0

—

Symptoms and signs involving the urinary system

1.27

0.26

1.0

—

Hypothyroidism, strict autoimmune

1.26

0.26

1.1

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

0.70

0.26

1.0

1.1

—

Intracranial injury

0.68

0.26

1.2

1.0

—

Dental operations

1.22

0.26

1.0

—

Diabetes medication

1.21

0.25

1.1

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

1.21

0.25

1.0

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.23

0.25

1.0

—

Diseases of the eye and adnexa

0.78

0.24

1.0

—

Diseases of the ear and mastoid process

1.19

0.24

1.1

1.0

—

Dizziness and giddiness

1.25

0.24

1.0

1.1

—

Accidents

1.21

0.23

1.0

—

Other external causes of accidental injury

1.21

0.23

1.0

—

Hypothyroidism, other/unspecified

1.24

0.23

1.2

1.0

—

Hard cardiovascular diseases

1.23

0.23

1.0

—

Carpal tunnel syndrome

1.28

0.23

1.0

—

Diseases of external ear

1.32

0.23

1.0

—

Iron deficiency anaemia

1.30

0.23

1.0

—

Other benign neoplasms of skin

1.28

0.23

1.0

—

Appendectomy

0.77

0.22

1.0

—

Polyarthropathies

1.24

0.22

1.0

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.24

0.22

1.0

1.1

—

Injuries to the head

0.82

0.22

1.1

1.0

—

Unstable angina pectoris

1.23

0.22

1.0

—

Persons with potential health hazards related to communicable diseases

1.24

0.22

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

1.28

0.22

1.1

—

Anxiety (asthma-related co-morbidities)

1.27

0.21

1.0

1.1

—

Type 2 diabetes, definitions combined

1.21

0.21

1.0

—

Neoplasms

1.23

0.21

1.0

1.1

—

Prolonged pregnancy

0.00

0.21

0.0

1.1

—

Medical observation and evaluation for suspected diseases and conditions

1.28

0.21

1.1

1.0

—

Crowding of teeth, including avohilmo

0.00

0.21

0.0

1.1

—

Mandibular retrognathia

0.00

0.21

0.0

1.1

—

Intermittent heterotropia

0.00

0.21

0.0

1.1

—

Fentanyl

0.00

0.21

0.0

1.0

—

Chronic viral hepatitis

0.00

0.21

0.0

1.0

—

Cerebral cysts

0.00

0.21

0.0

1.0

—

Desensitization to allergens

0.00

0.21

0.0

1.1

—

Benign neoplasm of brain and other parts of central nervous system

0.00

0.21

0.0

1.0

—

Foreign body or object entering through skin

0.00

0.21

0.0

1.0

—

Other viral hepatitis

0.00

0.21

0.0

1.0

—

Crohn disease (strict definition, require KELA, min 2 HDR)

0.00

0.21

0.0

1.0

—

Crohn disease (strict definition, require KELA)

0.00

0.21

0.0

1.0

—

Hypoglycaemia, other or unspecified

0.00

0.21

0.0

1.0

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

0.00

0.21

0.0

1.1

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

0.00

0.21

0.0

1.0

—

Contact with other sharp object(s)

0.00

0.21

0.0

1.1

—

Other sexually transmitted chlamydial diseases

0.00

0.21

0.0

1.1

—

Reactive arthropathies, FINNGEN

0.00

0.21

0.0

1.0

—

Exposure to other and unspecified inanimate mechanical forces

0.00

0.21

0.0

1.0

—

Amputation

0.00

0.21

0.0

1.0

—

Viral hepatitis

0.00

0.21

0.0

1.0

—

Other coagulation defects

0.00

0.21

0.0

1.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

0.00

0.21

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

0.00

0.21

0.0

1.0

—

Benign neoplasm of middle ear and respiratory system

0.00

0.21

0.0

1.0

—

Other peripheral vascular diseases

0.00

0.21

0.0

1.0

—

Other congenital malformations of skin

0.00

0.21

0.0

1.1

—

Assault by bodily force

0.00

0.21

0.0

1.0

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

0.21

0.0

1.0

—

Other and unspecified myopathies

0.00

0.21

0.0

1.0

—

Malignant neoplasm of pancreas, including Hilmo

0.00

0.21

0.0

1.0

—

Malignant neoplasm of kidney, except renal pelvis

0.00

0.21

0.0

1.0

—

Raynaud syndrome

0.00

0.21

0.0

1.0

—

Vestibular neuronitis

0.00

0.21

0.0

1.0

—

Streptococcal septicaemia

0.00

0.21

0.0

1.0

—

Non-follicular lymphoma

0.00

0.21

0.0

1.0

—

Stenosis and insufficiency of lacrimal passages

0.00

0.21

0.0

1.0

—

Amiodarone users

0.00

0.21

0.0

1.0

—

Malignant neoplasm of urinary organs

0.00

0.21

0.0

1.0

—

Brachial plexus disorders

0.00

0.21

0.0

1.0

—

Sudden idiopathic hearing loss

0.00

0.21

0.0

1.0

—

Disorders of continuity of bone

0.00

0.21

0.0

1.0

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

0.00

0.21

0.0

1.0

—

Plantar fascial fibromatosis

0.00

0.21

0.0

1.0

—

Unspecified kidney failure

0.00

0.21

0.0

1.0

—

Ptosis of eyelid

0.00

0.21

0.0

1.0

—

Colon adenocarcinoma

0.00

0.21

0.0

1.0

—

Anogenital herpesviral [herpes simplex] infection

0.00

0.21

0.0

1.1

—

LSIL lesion of the cervix uteri

0.00

0.21

0.0

1.0

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

0.00

0.21

0.0

1.0

—

Other disorders of breast

0.00

0.21

0.0

1.0

—

Budesonide

0.00

0.21

0.0

1.0

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

0.00

0.21

0.0

1.1

—

Hypertension, essential

1.23

0.21

1.0

—

Propionic acid derivatives

1.31

0.21

1.0

—

Injury of unspecified body region

0.00

0.21

0.0

1.0

—

Nail disorders

0.00

0.21

0.0

1.0

—

Smoking dependency

0.00

0.21

0.0

1.0

—

Mental and behavioural disorders due to tobacco

0.00

0.21

0.0

1.0

—

Abnormal weight loss

0.00

0.21

0.0

1.1

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

0.00

0.21

0.0

1.0

—

Other disorders of glucose regulation and pancreatic internal secretion

0.00

0.21

0.0

1.0

—

Sequelae of injuries of upper limb

0.00

0.21

0.0

1.0

—

Other psoriatic arthropathies

0.00

0.21

0.0

1.0

—

Psoriatic arthropathies, ICD10

0.00

0.21

0.0

1.0

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

0.21

0.0

1.0

—

Unspecified privation

0.00

0.21

0.0

1.0

—

Pruritus

0.00

0.21

0.0

1.0

—

Agranulocytosis

0.00

0.21

0.0

1.0

—

Chalazion

0.00

0.21

0.0

1.0

—

Coeliac disease

0.00

0.21

0.0

1.0

—

Use of levodopa decarboxylase inhibitor

0.00

0.21

0.0

1.0

—

Inflammatory disease of uterus

0.00

0.21

0.0

1.0

—

Other intervertebral disc disorders

1.22

0.21

1.0

—

Endometriosis of ovary

0.00

0.21

0.0

1.2

—

Parkinson's disease, strict definition, excluding more controls

0.00

0.21

0.0

1.0

—

Parkinson's disease, excluding more controls

0.00

0.21

0.0

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.22

0.21

1.2

1.0

—

Crushed, pushed or stepped on by crowd or human stampede

0.00

0.21

0.0

1.1

—

Neuromuscular dysfunction of bladder

0.00

0.21

0.0

1.0

—

Malignant melanoma of skin

0.00

0.21

0.0

1.0

—

Arthropathic psoriasis

0.00

0.21

0.0

1.0

—

Other mental disorders due to brain damage and dysfunction and to physical disease

0.00

0.21

0.0

1.0

—

Other sexually transmitted chlamydial diseases

0.00

0.21

0.0

1.1

—

Family history of malignant neoplasm

0.00

0.21

0.0

1.0

—

Injuries to unspecified part of trunk, limb or body region

0.00

0.21

0.0

1.1

—

Lichen planus

0.00

0.21

0.0

1.0

—

Restless leg syndrome

0.00

0.21

0.0

1.0

—

Parkinson's disease, strict definition

0.00

0.21

0.0

1.0

—

Parkinson's disease

0.00

0.21

0.0

1.0

—

Other symptoms and signs involving the digestive system and abdomen

0.00

0.21

0.0

1.1

—

Other disorders of penis

0.00

0.21

0.0

1.0

—

Intracerebral haemorrhage

0.00

0.21

0.0

1.0

—

Delirium, not induced by alcohol and other psychoactive substances

0.00

0.21

0.0

1.0

—

Deep bite

0.00

0.20

0.0

1.1

—

Vitreous haemorrhage

0.00

0.20

0.0

1.0

—

Superficial injury of forearm

0.00

0.20

0.0

1.1

—

Psoriatic and enteropathic arthropathies

0.00

0.20

0.0

1.0

—

Migraine without aura and triptan purchases

0.00

0.20

0.0

1.1

—

Hernia of abdominal wall, postoperative

0.00

0.20

0.0

1.0

—

L02BA Anti-estrogens

0.00

0.20

0.0

1.0

—

Diseases of the digestive system

1.24

0.20

1.2

1.0

—

Presence of cardiac and vascular implants and grafts

1.20

0.20

1.0

—

Any mental disorder

1.17

0.19

1.1

1.0

—

Nutritional anaemias

1.18

0.19

1.0

—

Noninfective enteritis and colitis

1.17

0.19

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.21

0.18

1.1

1.0

—

Triptan medication for migraine, single purchase ok

1.21

0.18

1.1

1.0

—

Recurrent or chronic depression

1.23

0.18

1.0

—

Viral infections characterized by skin and mucous membrane lesions

1.19

0.18

1.1

1.0

—

Codes for special purposes

1.18

0.18

1.0

—

Provisional assignment of new diseases of uncertain etiology

1.18

0.18

1.0

—

Mood disorders, excluding more controls

1.18

0.18

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.17

0.18

1.1

—

Type 2 diabetes, strict (exclude DM1)

1.17

0.17

1.0

—

Stroke, excluding SAH

0.72

0.17

1.0

—

Gonarthrosis, primary, with knee surgery

0.71

0.17

1.0

—

Coxarthrosis, primary

0.72

0.17

1.0

—

Diseases of middle ear and mastoid

1.19

0.17

1.1

1.0

—

Caries of dentine, including avohilmo

1.20

0.16

1.1

1.0

—

Disorders of sclera, cornea, iris and ciliary body

1.16

0.16

1.1

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

1.16

0.16

1.0

—

Missing teeth due to accident, extraction or parodontitis

0.77

0.15

1.2

1.0

—

Acute appendicitis, no complications

0.80

0.15

1.0

1.1

—

Alcohol use disorder, Swedish definition

0.76

0.15

1.0

—

Necrosis of pulp, including avohilmo

1.15

0.15

1.2

1.0

—

Diseases of arteries, arterioles and capillaries

1.11

0.15

1.0

—

Headache

0.80

0.14

1.0

1.1

—

Other dorsopathies, not elsewhere classified

1.15

0.14

1.0

—

Other neurological diseases

1.19

0.13

1.0

—

Complications of procedures, not elsewhere classified

0.85

0.13

1.0

—

Cholelithiasis

1.16

0.13

1.1

1.0

—

Hernia

0.87

0.11

1.0

—

Senile cataract

1.18

0.11

1.0

—

Injuries to the ankle and foot

1.15

0.10

1.0

—

Implicit Sepsis

1.15

0.10

1.0

—

Falls/tendency to fall

0.89

0.10

1.0

—

Complications of surgical and medical care, not elsewhere classified

0.88

0.10

1.0

—

Codeine or tramadol medication

1.11

0.10

1.0

—

Disorders of breast

1.13

0.10

1.0

1.1

—

Heart failure and coronary heart disease

1.11

0.10

1.0

—

Appendicitis, broad definition

1.14

0.10

1.0

—

Degeneration of macula and posterior pole

1.10

0.10

1.2

1.0

—

Non-selective monoamine reuptake inhibitors

1.07

0.09

1.0

—

Fracture at wrist and hand level

1.06

0.09

1.0

—

Other joint disorders

1.11

0.09

1.0

—

Myocardial infarction

1.11

0.09

1.0

—

Depression

1.12

0.09

1.0

—

Other and unspecified dermatitis

1.11

0.09

1.2

1.0

—

Disorders of skin appendages

1.11

0.09

1.2

1.0

—

Injuries to the thorax

1.05

0.08

1.0

—

Use of hypnotics and sedatives

0.90

0.08

1.1

1.0

—

Conductive and sensorineural hearing loss

1.12

0.08

1.1

1.0

—

Erysipelas

1.11

0.08

1.0

—

Allergic conjunctivitis

1.10

0.08

1.1

1.0

—

Acute tubulo-interstitial nephritis

1.08

0.08

1.0

—

Excessive earwax

1.07

0.08

1.0

—

Presence of other functional implants

1.03

0.08

1.0

—

Coxarthrosis

0.84

0.08

1.0

—

STROKE

0.83

0.08

1.0

—

Concussion

1.09

0.07

1.1

—

Codeine

1.10

0.07

1.0

1.1

—

Dermatophytosis

1.07

0.07

1.0

—

Fracture of lower leg, including ankle

1.06

0.07

1.0

—

Lumbar disc prolapse

0.87

0.07

1.0

—

Meniscus derangement

0.83

0.07

1.0

—

0.85

0.07

1.0

—

Other nutritional deficiencies

0.87

0.07

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

0.85

0.07

1.0

1.1

—

Care involving use of rehabilitation procedures

0.85

0.07

1.0

1.1

—

Infections of the skin and subcutaneous tissue

0.87

0.07

1.1

1.0

—

0.83

0.07

1.0

—

Substance abuse

0.84

0.07

1.0

—

Mental and behavioural disorders due to psychoactive substance use

0.82

0.07

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

1.08

0.07

1.0

1.1

—

Inguinal hernia

0.88

0.07

1.0

—

Cerebrovascular diseases

0.84

0.07

1.0

—

Complications of medical and surgical care

0.88

0.06

1.0

—

Diseases of appendix

1.11

0.06

1.0

—

Other heart diseases, wide

1.10

0.06

1.0

1.1

—

Pain in limb

0.89

0.06

1.0

—

Neurological diseases

1.10

0.06

1.0

1.1

—

Cholelithiasis, broad definition with cholecystitis

1.11

0.06

1.1

1.0

—

Persons encountering health services for specific procedures and health care

0.92

0.05

1.0

—

Injuries to the elbow and forearm

1.11

0.05

1.0

—

Implicit Sepsis

1.10

0.05

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.08

0.05

1.0

—

Finngen Rheumatological endpoints

1.08

0.05

1.0

—

Erysipelas

1.11

0.04

1.0

—

Caries of enamel

1.08

0.04

1.0

—

Soft tissue disorders

0.93

0.03

1.0

—

Sensorineural hearing loss

1.08

0.03

1.1

1.0

—

Injuries to the wrist and hand

0.94

0.03

1.1

1.0

—

Other disorders of ear

1.06

0.02

1.1

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

0.94

0.02

1.1

1.0

—

Statin medication

1.07

0.01

1.0

1.1

—

Exposure to unspecified factor

0.95

0.00

1.1

1.0

—

Dorsopathies

1.05

0.00

1.0

—

Other (not insulin) diabetes medications

0.99

0.00

1.0

—

Arthropathies

1.00

0.00

1.0

—

Conjunctivitis

1.06

0.00

1.1

1.0

—

Selective serotonin reuptake inhibitors

0.99

0.00

1.1

1.0

—

Sleep disorders (combined)

0.98

0.00

1.0

1.1

—

Other specific joint derangements/joint disorders

1.02

0.00

1.0

—

Nerve, nerve root and plexus disorders

1.03

0.00

1.0

—

Disorders of the thyroid gland

1.00

0.00

1.0

—

Hypertension

1.04

0.00

1.0

1.1

—

Shoulder lesions

0.96

0.00

1.0

—

Biguanides

0.99

0.00

1.0

—

Tramadol

0.97

0.00

1.0

—

Disorders of lens

1.06

0.00

1.0

—

Hypertensive diseases

1.04

0.00

1.0

1.1

—

Opioids

1.04

0.00

1.0

1.1

—

Disorders of eyelid, lacrimal system and orbit

0.98

0.00

1.0

—

Diverticular disease of intestine

0.98

0.00

1.0

—

Injuries to the knee and lower leg

1.00

0.00

1.0

—

Disorders of conjunctiva

1.01

0.00

1.1

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.04

0.00

1.1

1.0

—

Transient global amnesia

0.00

0.0

1.0

—

Other and unspecified mood [affective] disorders

0.00

0.0

1.1

—

Vascular dementia (subcortical)

0.00

0.0

1.0

—

Extracorporeal dialysis

0.00

0.0

1.0

—

Sacroiliitis, not elsewhere classified

0.00

0.0

1.0

—

Other specified and unspecified disorders of eye and adnexa

0.00

0.0

1.0

—

Burns and corrosions confined to eye and internal organs

0.00

0.0

1.0

—

Vasomotor rhinitis (mode)

0.00

0.0

1.0

—

Distal bite

0.00

0.0

1.1

—

Pneumonia due to Streptococcus pneumoniae

0.00

0.0

1.0

—

Unspecified haematuria

0.94

0.00

1.0

—

Mental and behavioural disorders due to alcohol

0.96

0.00

1.0

—

Respiratory tuberculosis, not confirmed

0.00

0.0

1.0

—

Varicella [chickenpox]

0.00

0.0

1.0

—

6-mercaptopurine

0.00

0.0

1.0

—

Primary angle-closure glaucoma

0.00

0.0

1.0

—

Burn and corrosion of trunk

0.00

0.0

1.0

—

Use of biperiden

0.00

0.0

1.0

—

Tongue abnormality

0.00

0.0

1.0

—

Impacted maxillary molar

0.00

0.0

1.1

—

Asymmetry of jaw

0.00

0.0

1.0

—

Lesion of plantar nerve

0.00

0.0

1.0

—

Congenital deformities of feet

0.00

0.0

1.0

—

Other/unspecified reactive arthropathies

0.00

0.0

1.0

—

Inflammatory disease of cervix uteri

0.00

0.0

1.0

—

Malignant neoplasm of small intestine, including Hilmo

0.00

0.0

1.0

—

Brain meningioma

0.00

0.0

1.0

—

Other Crohn's disease

0.00

0.0

1.0

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.00

0.0

1.0

—

Other salmonella infections

0.00

0.0

1.0

—

Glaucoma, exfoliation

0.00

0.0

1.0

—

Amblyopia ex anopsia

0.00

0.0

1.1

—

Diseases of tongue

0.00

0.0

1.0

—

Chronic periodontitis, complicated

0.95

0.00

1.0

—

Melanocytic naevi, other sites/unspecified

0.00

0.0

1.0

—

Presbyopia

0.00

0.0

1.0

—

Fracture of neck

0.00

0.0

1.0

—

Coxarthrosis [arthrosis of hip](FG)

0.95

0.00

1.0

—

Malignant neoplasm, without specification of site

0.00

0.0

1.0

—

Other salmonella infections

0.00

0.0

1.0

—

Anogenital herpesviral [herpes simplex] infection

0.00

0.0

1.0

—

Malignant neoplasm of pancreas

0.00

0.0

1.0

—

Acute posthaemorrhagic anaemia

0.00

0.0

1.0

—

Injury of nerves at wrist and hand level

0.00

0.0

1.0

—

Other specified/unspecified hearing loss

0.00

0.0

1.0

—

Malignant neoplasm of oral cavity, including Hilmo

0.00

0.0

1.0

—

Use of antiglaucoma preparations and miotics

0.00

0.0

1.0

—

Biomechanical lesions, not elsewhere classified

0.00

0.0

1.0

—

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

0.00

0.0

1.0

—

Cyst of kidney

0.00

0.0

1.0

—

Triptan medication for migraine, min. 3 purchases

0.97

0.00

1.0

1.1

—

L01XE Protein kinase inhibitors

0.00

0.0

1.0

—

L02BX Other hormone antagonists and related agents

0.00

0.0

1.0

—

Gingival hyperplasia

0.00

-0.00

0.0

1.0

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

0.00

-0.00

0.0

1.0

—

Diffuse brain injury

0.00

-0.00

0.0

1.0

—

Focal brain injury

0.00

-0.00

0.0

1.0

—

Dislocation, sprain and strain of joint and ligaments of hip

0.00

-0.00

0.0

1.0

—

Foreign body in alimentary tract

0.00

-0.00

0.0

1.0

—

Intracranial trauma

0.94

-0.00

1.1

—

Other and unspecified injuries of lower leg

0.00

-0.00

0.0

1.1

—

Other symptoms and signs involving general sensations and perceptions

0.00

-0.00

0.0

1.0

—

Open wound of shoulder and upper arm

0.00

-0.00

0.0

1.0

—

Other and unspecified injuries of wrist and hand

0.00

-0.00

0.0

1.0

—

Other and unspecified injuries of head

0.00

-0.00

0.0

1.0

—

Open wound of head

0.98

-0.00

1.0

—

Somnolence, stupor and coma

0.00

-0.00

0.0

1.0

—

Open wound of hip and thigh

0.00

-0.00

0.0

1.0

—

Sequelae of injuries of neck and trunk

0.00

-0.00

0.0

1.0

—

Traumatic subarachnoid haemorrhage

0.00

-0.00

0.0

1.0

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

-0.00

0.0

1.0

—

Crystal arthropathies, rheuma endpoint

0.00

-0.00

0.0

1.0

—

Exposure to other specified electric current

0.00

-0.00

0.0

1.0

—

Unspecified urinary incontinence

0.00

-0.00

0.0

1.0

—

Other abnormal findings of blood chemistry

0.00

-0.00

0.0

1.0

—

Fall on and from ladder

0.00

-0.00

0.0

1.0

—

Contact with sharp glass

0.00

-0.00

0.0

1.0

—

Other maltreatment syndromes

0.00

-0.00

0.0

1.0

—

Car occupant injured in noncollision transport accident

0.00

-0.00

0.0

1.0

—

Motorcycle rider injured in noncollision transport accidents

0.00

-0.00

0.0

1.0

—

Transport accidents

1.00

-0.00

1.1

—

Pedestrian injured in collision with pedal cycle

0.00

-0.00

0.0

1.0

—

Other orthopaedic follow-up care

0.00

-0.00

0.0

1.0

—

Other ill-defined and unspecified causes of mortality

0.00

-0.00

0.0

1.0

—

Fall involving bed

0.00

-0.00

0.0

1.0

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

0.00

-0.00

0.0

1.0

—

Other dialysis

0.00

-0.00

0.0

1.0

—

Disturbances of smell and taste

0.00

-0.00

0.0

1.0

—

Other general symptoms and signs

0.00

-0.00

0.0

1.2

—

Other medical care

0.88

-0.00

1.0

—

Follow-up care involving plastic surgery

0.00

-0.00

0.0

1.0

—

Personal history of malignant neoplasm

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS